Moderna Inc Asset Turnover Ratio (MRNA), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Moderna Inc   (NASDAQ: MRNA)
 

Moderna Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Moderna Inc asset turnover ratio, the ability of Moderna Inc 's assets to generate revenue in the second quarter 2026, increased sequentially to 0.19 in the second quarter (Jun 30 2026), yet the ratio remained below the average, as MRNA's position remain challenging.

Within sector 23 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 1818 to 1924.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MRNA Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change -8.73 % -9.57 % -9.57 % -23.21 % -23.41 %
Y / Y Revenue Change 2.11 % 260.19 % -29.81 % -45.44 % -41.08 %
Asset Turnover Ratio (TTM) 0.19 0.18 0.16 0.18 0.23
MRNA's Total Ranking # 1924 # 1818 # 2133 # 2047 # 1995
Seq. Asset Change -4.59 % -10.17 % 5.38 % 1.04 % -5.46 %
Seq. Revenue Change -62.72 % -42.63 % -33.27 % 615.49 % 31.48 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 24
Healthcare Sector # 245
Overall Market # 1924

Asset Turnover Ratio Statistics
High Average Low
7.94 5.67 0.64
(Sep 30 2023)   (Sep 30 2019)




MRNA Company Profile • Back to MRNA Efficiency Comparisons • Compare MRNA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Vireo Growth Inc.  0.55 $ 511.706  Millions$ 924.643  Millions
Ceribell Inc   0.55 $ 101.804  Millions$ 184.939  Millions
Cormedix Inc   0.55 $ 451.943  Millions$ 824.173  Millions
Stryker Corp  0.55 $ 25,837.000  Millions$ 47,280.500  Millions
Gilead Sciences Inc   0.55 $ 30,457.000  Millions$ 55,799.000  Millions
Viskase Holdings inc   0.55 $ 177.054  Millions$ 324.798  Millions
Bristol myers Squibb Company  0.54 $ 49,186.000  Millions$ 90,259.250  Millions
Transmedics Group Inc   0.54 $ 668.468  Millions$ 1,228.405  Millions
American Shared Hospital Services  0.54 $ 30.210  Millions$ 55.582  Millions
Ultragenyx Pharmaceutical Inc   0.54 $ 717.212  Millions$ 1,320.611  Millions
Integer Holdings Corporation  0.54 $ 1,842.621  Millions$ 3,410.801  Millions
Glaukos Corp  0.54 $ 500.031  Millions$ 926.678  Millions
Icu Medical Inc  0.54 $ 2,159.998  Millions$ 4,034.612  Millions
Charles River Laboratories International inc   0.53 $ 3,998.987  Millions$ 7,477.922  Millions
Foxo Technologies Inc   0.53 $ 24.846  Millions$ 47.087  Millions
Rhythm Pharmaceuticals Inc   0.51 $ 239.918  Millions$ 466.663  Millions
Brookdale Senior Living Inc   0.51 $ 3,050.697  Millions$ 5,941.145  Millions
Envista Holdings Corporation  0.51 $ 2,856.400  Millions$ 5,624.150  Millions
Merck and Co Inc   0.51 $ 66,569.000  Millions$ 131,224.750  Millions
Cryo cell International Inc   0.51 $ 31.128  Millions$ 61.622  Millions
Clearpoint Neuro Inc   0.50 $ 42.279  Millions$ 84.565  Millions
Orthopediatrics Corp  0.50 $ 251.278  Millions$ 503.924  Millions
Carlsmed Inc   0.50 $ 62.457  Millions$ 125.489  Millions
Alkermes Plc   0.50 $ 1,667.652  Millions$ 3,366.927  Millions
Rapid Micro Biosystems Inc   0.49 $ 34.545  Millions$ 70.018  Millions
Johnson and Johnson  0.49 $ 97,929.000  Millions$ 198,495.250  Millions
Insmed Inc  0.49 $ 1,076.572  Millions$ 2,200.931  Millions
Perrigo Company Plc  0.48 $ 4,144.000  Millions$ 8,553.000  Millions
Tenon Medical Inc   0.48 $ 5.312  Millions$ 10.971  Millions
Vertex Pharmaceuticals Inc  0.48 $ 12,587.200  Millions$ 26,103.250  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.